Data is the New Battlefied
AspenTech Inmation Briefing Note Axendia was recently briefed by the Pharmaceutical and DataWorks Business Units at Aspen Technology, Inc., (AspenTech) on the acquisition of Inmation™, …
FDA Announces IT Strategy for Fiscal Years 2024 to 2027
Comments Due by October 30, 2023 On September 19, 2023 FDA released its IT Strategy for FY 2024 – 2027. In 2009, Axendia completed a …
FDA Announces IT Strategy for Fiscal Years 2024 to 2027 Read More »
Simplifying the Digital Factory with Multi-Tenant Cloud MES
42Q Briefing Note Axendia was recently briefed by the leadership team at 42Q, a product division of Sanmina Corporation. With over thirty years of experience, …
Simplifying the Digital Factory with Multi-Tenant Cloud MES Read More »
Say Hello to Dottie: Combining Quality, Compliance and Production Optimization with AI
Dot Compliance Briefing Note Axendia was recently briefed by the executive team at Dot Compliance, on its newly released, ready-to-use AI-powered QMS. Headquartered in Phoenix, …
Say Hello to Dottie: Combining Quality, Compliance and Production Optimization with AI Read More »
Optimizing Transformation
Event Brief: Honeywell User Group Meeting 2023 Honeywell held its 46th global annual user group meeting (HUG) in Orlando, FL from 19-21 June 2023. The …
Are You Listening to Your Signal Chain?
Rootstock Briefing Note Axendia was recently briefed by the executive team at Rootstock, a cloud ERP solution natively built on the Salesforce Platform for companies …
The Future Is Not Something We Enter. The Future is Something We Create.
Event Brief: PTC LiveWorx 2023 Axendia’s Sr. Industry Analyst, Sandra K. Rodriguez, was invited to attend and cover PTC’s LiveWorx 2023 at the Boston Convention …
The Future Is Not Something We Enter. The Future is Something We Create. Read More »
Harnessing the Power of PLM
Webinar Available On-Demand Axendia’s Sr. Industry Analyst, Sandra K. Rodriguez, was joined by Leigh Young, PLM Product Manager at Aras Corporation to discuss how industry …
Artificial Intelligence has the Attention of Regulators
“The regulatory uses of AI are real: In 2021, more than 100 drug and biologic applications submitted to the FDA included AI/ML components. These submissions …
Artificial Intelligence has the Attention of Regulators Read More »
ConQuest 2023: Innovations to Drive Collaboration and Empowerment
Event Brief: ComplianceQuest Inaugural User Conference Axendia’s Sr. Industry Analyst, Sandra K. Rodriguez, was invited to attend the Inaugural ComplianceQuest User Conference, ConQuest, at the …
ConQuest 2023: Innovations to Drive Collaboration and Empowerment Read More »
No Instrument Left Behind
Scitara Briefing Note Axendia was recently briefed by Jeffrey Mazzeo, Ph.D., chief marketing officer at Scitara Corporation. The company was started three years ago with …
Life Science Industry Predictions for 2023 and Beyond!
An Axendia “Straight from the Source” Event Axendia revealed its 2023 Life Sciences Radar on February 2, 2023, during a live event. Members of our …
Life Science Industry Predictions for 2023 and Beyond! Read More »